2008
DOI: 10.1016/j.taap.2007.10.013
|View full text |Cite
|
Sign up to set email alerts
|

Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
36
0
2

Year Published

2012
2012
2018
2018

Publication Types

Select...
4
3
1

Relationship

1
7

Authors

Journals

citations
Cited by 42 publications
(41 citation statements)
references
References 35 publications
3
36
0
2
Order By: Relevance
“…A total of 360 SNPs and 18 genes were genotyped, and the investigators identified novel single nucleotide polymorphisms (SNPs) in ICAM-1 and VCAM-1 that had significant interactions with well-water arsenic in CVD risk which remained robust after adjustment for multiple testing [94]. Regarding subclinical cardiovascular endpoints, the majority of evidence comes from a series of studies conducted in Taiwan that found the prevalence of arsenic-related carotid atherosclerosis was modifiable by genetic polymorphisms related to oxidative stress, inflammation, and arsenic metabolism [95-99]. However, these studies have included a limited number of genetic variants and did not have enough sample size to evaluate the effect-modification at low levels of exposure.…”
Section: Susceptibility To Arsenic-induced Subclinical Endpointsmentioning
confidence: 99%
“…A total of 360 SNPs and 18 genes were genotyped, and the investigators identified novel single nucleotide polymorphisms (SNPs) in ICAM-1 and VCAM-1 that had significant interactions with well-water arsenic in CVD risk which remained robust after adjustment for multiple testing [94]. Regarding subclinical cardiovascular endpoints, the majority of evidence comes from a series of studies conducted in Taiwan that found the prevalence of arsenic-related carotid atherosclerosis was modifiable by genetic polymorphisms related to oxidative stress, inflammation, and arsenic metabolism [95-99]. However, these studies have included a limited number of genetic variants and did not have enough sample size to evaluate the effect-modification at low levels of exposure.…”
Section: Susceptibility To Arsenic-induced Subclinical Endpointsmentioning
confidence: 99%
“…Residents who had been exposed to high levels of As (>50 μg/L) had an age-and gender-adjusted odds ratio (OR) of 3.3 for developing carotid atherosclerosis while those who had been exposed to low (≤10 μg/L) and mid-levels (10.1-50 μg/L) of As had an OR of 1.0 and 1.4, respectively [60]. Similarly, Hsieh and co-workers also showed a dose-dependent relationship between As exposure and increased risk of carotid atherosclerosis in Taiwan [61]. Residents who had been exposed to high levels of As in drinking water (≥50 μg/L) with a cumulative arsenic exposure (CAE) of ≥1.1 mg/L/year had an age-and gender-adjusted OR of 2.4 and 1.9 for developing carotid atherosclerosis, respectively (p < 0.05).…”
Section: Clinical Studiesmentioning
confidence: 94%
“…On similar lines, polymorphism within lipid metabolism and inflammation genes has also been shown to be linked to CVD. The relationship of polymorphism in APOE (lipid metabolism gene) and MCP-1 (inflammation gene) with the risk of carotid atherosclerosis was evaluated in 479 arsenic-exposed residents of Taiwan [61]. Residents with a carotid artery IMT thickness of ≥1.0 mm or with observable plaque in the extra-cranial carotid artery were diagnosed as having carotid arteriosclerosis.…”
Section: Genetic Polymorphismsmentioning
confidence: 99%
“…Epidemiologic evidence suggests a positive association between As exposure and cIMT [2]. In addition, some studies indicate that genetic factors could modify the cardiovascular effects of As exposure [3-7]. However, existing studies have limitations such as a small number of clinical cases of CVD and the inclusion of a limited number of genetic variants.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, in addition to genetic variants related to As metabolism, those involved in these mechanisms such as heme oxygenase 1 ( HMOX1 ), nitric oxide synthase 3 ( NOS3 ), superoxide dismutase 2 ( SOD2 ), alpha polypeptide ( CYBA ), apolipoprotein E ( APOE ), tumor necrosis factor ( TNF ), interleukin 6 ( IL6 ), intercellular adhesion molecule 1 ( ICAM1 ), sphingosine-1-phosphate receptor 1 ( S1PR1 ), and vascular cell adhesion molecule 1 ( VCAM1 ) may also modify the cardiovascular effects of As exposure. A few studies in Taiwan have investigated whether As-induced carotid atherosclerosis can be modified by polymorphisms in HMOX1 , NOS3 , SOD2 , CYBA , and APOE genes [3, 6, 7]. However, larger studies with a comprehensive selection of SNPs are needed to confirm the findings.…”
Section: Introductionmentioning
confidence: 99%